PAH and pulmonary arterial hypertension: For instance, the off‐target effect of panobinostat on phenylalanine hydroxylase (PAH) has been identified,87 and the binding of panobinostat to PAH results in increased cellular phenylalanine and decreased tyrosine levels, which are associated with the side effects of the drug.87